Get the Stockscreener App
51.52
0.43%
-0.22
Pre-market:
51.52
Phibro Animal Health Corp stock is traded at $51.52, with a volume of 352.56K.
It is down -0.43% in the last 24 hours and up +30.63% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$51.74
Open:
$51.8
24h Volume:
352.56K
Relative Volume:
1.25
Market Cap:
$2.09B
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
139.24
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
+25.66%
1M Performance:
+30.63%
6M Performance:
+80.46%
1Y Performance:
+97.24%
1-Day Range:
$51.30
$52.47
1-Week Range:
$43.17
$56.30
52-Week Range:
$16.16
$56.30
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
51.52 | 2.10B | 982.01M | 14.80M | 37.02M | 0.37 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Aug Rallies: Is Phibro Animal Health Corporation gaining market shareJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Why Phibro (PAHC) International Revenue Trends Deserve Your Attention - Yahoo Finance
Penserra Capital Management LLC Makes New $519,000 Investment in Phibro Animal Health Corporation $PAHC - Defense World
Phibro Animal Health Signals Strong Momentum in Earnings - TipRanks
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12 - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2026 Earnings Call Transcript - Insider Monkey
3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Phibro Animal Health Q2 Earnings Call Highlights - Yahoo Finance
Phibro Animal Health (PAHC) Margin Rebound And EPS Surge Test Cautious Growth Narratives - simplywall.st
Phibro Animal Health (PAHC) Is Up 25.3% After Issuing 2026 Sales And EPS GuidanceWhat's Changed - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call Highlight - GuruFocus
Phibro Animal Health stock hits 52-week high at $46.95 - Investing.com
Phibro Animal Health now targets up to 85% profit growth in 2026 - Stock Titan
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Phibro Q2 2026 presentation: Animal Health drives 21% revenue growth, guidance raised - Investing.com
Earnings call transcript: Phibro Animal Health beats Q2 2026 forecasts, stock surges - Investing.com
Chart Watch: What is the long term forecast for Phibro Animal Health Corporation stockQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn
Phibro Animal Health Fiscal Q2 Adjusted Earnings, Sales Rise; Lifts FY26 Outlook; Shares Soar Premarket - marketscreener.com
Decoding Phibro Animal Health Corp (PAHC): A Strategic SWOT Insi - GuruFocus
Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Misses Q2 CY2026 Revenue Estimates, But Stock Soars 5.5% - Finviz
Phibro: Overview of Second Quarter Financial Results - Bitget
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
PAHC Updates FY26 Revenue Projections, Surpassing Expectations - GuruFocus
Phibro: Fiscal Q2 Earnings Snapshot - marketscreener.com
Phibro Animal Health Corporation Reports Strong Q2 Results and Updates Financial Guidance - TradingView
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance - Yahoo Finance
Phibro Animal Health declares $0.12 quarterly dividend - Investing.com
Animal health company to pay $0.12 per share dividend in March - Stock Titan
Earnings Preview For Phibro Animal Health - Benzinga
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 6,693 Shares of Stock - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) CEO Sells $271,692.64 in Stock - MarketBeat
A Look At Phibro Animal Health (PAHC) Valuation After Strong 1 Year Returns And Recent Pullback - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Phibro Animal Health (PAHC) and Unicycive Therapeutics (UNCY) - The Globe and Mail
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz
Hussman Strategic Advisors Inc. Sells 42,000 Shares of Phibro Animal Health Corporation $PAHC - MarketBeat
Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results - Yahoo Finance
Reasons to Retain Baxter International Stock in Your Portfolio Now - Finviz
PAHC Q2 Earnings Preview: Animal Health Momentum Likely to Aid Results - Yahoo Finance
What makes Prothena Corporation plc stock price move sharply - baoquankhu1.vn
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance
Lobbying Update: $30,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed - Quiver Quantitative
Phibro Animal Health (NASDAQ:PAHC) Shares Down 5% Following Insider Selling - MarketBeat
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Phibro Animal Health (PAHC) director sells $1.16 million in stock By Investing.com - Investing.com UK
Phibro Animal Health (PAHC) director sells $1.16 million in stock - Investing.com
Why The Narrative Around Phibro Animal Health (PAHC) Is Shifting With The New Price Target - Yahoo Finance
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):